SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-012940 to Alternative Ballistics Corp (CIK 0001834868) (ALBC)

Alternative Ballistics Corp (CIK 0001834868)
Date: Nov. 28, 2023 · CIK: 0001834868 · Accession: 0000000000-23-012940

AI Filing Summary & Sentiment

File numbers found in text: 024-12349

Date
November 28, 2023
Author
Not clearly detected
Form
UPLOAD
Company
Alternative Ballistics Corp (CIK 0001834868)

Letter

United States securities and exchange commission logo November 28, 2023 Steven Luna Chief Executive Officer Alternative Ballistics Corporation 5940 S. Rainbow Blvd. Las Vegas, Nevada 89118 Re:Alternative Ballistics Corporation Amendment No. 1 to Offering Statement on Form 1-A Filed November 6, 2023 File No. 024-12349 Dear Steven Luna: We have reviewed your amended offering statement and have the following comment(s). Please respond to this letter by amending your offering statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your offering statement and the information you provide in response to this letter, we may have additional comments. Amendment No 1 to Registration Statement on Form 1-A Cover page 1.We note your disclosure that the offering will “terminate at the earlier of (i) the date at which the Maximum Offering set forth above has been sold, or (ii) the date at which this Offering is earlier terminated by us at our sole discretion.” We also note your disclosure on page 6 that the offering will "terminate at the earlier of (i) the date at which the Maximum Offering set forth above has been sold, (ii) one year from the qualification of this Offering, or (iii) the date at which this Offering is earlier terminated by us at our sole discretion." Please revise. 2.We note your disclosures that your directors, executive officers and significant stockholders may be able to influence your company and that your Chief Executive Officer has 68.2% voting control “through his ownership of 2,000,000 shares of Series A Preferred Stock, which has 100 to 1 voting rights.” If true, please revise the cover page to prominently disclose that the company will be a controlled company post-offering, identify the controlling stockholder(s) and such stockholders’ total voting power, and

FirstName LastNameSteven Luna Comapany NameAlternative Ballistics Corporation November 28, 2023 Page 2 FirstName LastName Steven Luna Alternative Ballistics Corporation November 28, 2023 Page 2 include appropriate risk factor disclosure. 3.We note your disclosure on page 52 that the "Selling Stockholders may only make offers and sales of their shares of up to 30% of the gross proceeds from this Offering.” Please revise your cover page to include this disclosure. 4.We note your disclosure that you are an emerging growth company and that more information can be found in the section entitled “Offering Circular Summary—Implications of Being an Emerging Growth Company,” however, this section does not appear. Please advise or revise. Further, please revise to include a risk factor disclosing that you are an emerging growth company and discuss any related material risks. Summary Financial Data, page 7 5.Please revise the table to remove the parenthetical disclosure indicating "audited" and "unaudited" above the columns since your auditors have not issued an audit report covering this table and therefore all amounts are unaudited. Instead, if true, you could revise the introductory paragraph to indicate that the amounts presented as of and for the six months ended June 30, 2023 and 2022 were derived from your unaudited interim financial statements, and the amounts presented as of and for the years ended December 31, 2022 and 2021 were derived from your audited financial statements, presented elsewhere in the filing. Use of Proceeds, page 23 6.We note your anticipated use of proceeds if you raise the Maximum Offering amount. Please revise to describe any anticipated material changes in the use of proceeds if all of the securities being qualified on the offering statement are not sold. Capitalization, page 24 7.We note that you only present a "pro forma as adjusted" column that gives effect to the maximum offering. Please revise the introductory paragraphs to clearly disclose that this is a best-efforts offering with no minimum offering required. Further, refer to the guidance in Rule 11-02(a)(10) of Regulation S-X and revise to provide additional columns that assume varying amounts of possible sales (e.g., 25%, 50%, 75%). 8.Please remove the parenthetical disclosure above the columns indicating that the "Pro Forma and Pro Forma As Adjusted are unaudited" and that the Actual amounts for June 30, 2023 have been "reviewed," since your auditors have not issued an audit or review report covering this table. We note that all amounts presented are unaudited. If true, you could revise the introductory paragraph to say that the amounts presented in the Actual column were derived from your unaudited interim financial statements for the six months ended June 30, 2023 included elsewhere in the filing.

FirstName LastNameSteven Luna Comapany NameAlternative Ballistics Corporation November 28, 2023 Page 3 FirstName LastName Steven Luna Alternative Ballistics Corporation November 28, 2023 Page 3 9.Please revise the table to correctly calculate total capitalization for all columns presented as the sum of total liabilities and total shareholders’ equity (deficit). For example, total capitalization as of June 30, 2023, in the Actual column, appears to be $105,990. Dilution, page 25 10.As this is a best-efforts offering with no minimum offering required, please revise the dilution information to include a sensitivity analysis reflecting varying amounts of possible sales (e.g., 25%, 50%, 75%), to supplement the current Maximum Offering presentation. Management's Discussion and Analysis of Financial Condition and Results of Operations Liquidity and Capital Resources, page 28 11.Please revise to describe all material cash requirements, including short-term and long- term requirements, and the anticipated source of funds needed to satisfy such cash requirements. Further, please revise this section to discuss all current material debt of the company. Business Our Historical Growth and Growth Strategy, page 36 12.We note your disclosure on page 8 that you have not produced any revenue as well as your disclosure that you recently secured your “first purchase order from a department in Florida, and may have generated anticipated purchase orders from several departments in South America.” If material, please revise to clearly describe the material terms of the purchase order, including if any purchase orders are non-binding. Management Directors and Executive Officers, page 43 13.Please revise to briefly discuss the specific experience, qualifications, attributes or skills that led to the conclusion that each of your directors should serve as your director. Certain Relationships and Related-Party Transactions, page 50 14.We note the related party transactions disclosed on pages F-9 and F-10. Additionally, we note your disclosure that Vanessa Luna’s consulting firm provided consultation services to you. Please revise to include the disclosures required by Item 13 of Form 1-A, including the dollar amount of each transaction. Security Ownership of Certain Beneficial Owners, Management, and Selling Stockholders, page 15.We note your disclosure that your Chief Executive Officer owns 2 million shares of your Series A Preferred Stock. Please revise this table to disclose the beneficial ownership of

FirstName LastNameSteven Luna Comapany NameAlternative Ballistics Corporation November 28, 2023 Page 4 FirstName LastName Steven Luna Alternative Ballistics Corporation November 28, 2023 Page 4 your Series A Preferred Stock. Plan of Distribution, page 62 16.We note your disclosure regarding rolling closings and that "[i]f the Initial Closing never occurs, the proceeds from the Offering will be promptly returned to investors." Please provide expanded disclosure regarding your rolling closings, including whether you may terminate the offering without ever having a closing. Please also provide us your analysis as to whether your offering should be considered to be a delayed offering and not a continuous offering within the meaning of Rule 251(d)(3)(i)(F) of Regulation A. Notes to the Financial Statements (Unaudited) 2. Significant Accounting Policies, page F-5 17.We note you recognized revenue in the six-month period that ended June 30, 2023. Please revise to disclose the source of that revenue and your revenue recognition policy. Refer to ASC 606-10-50. In addition, revise your MD&A to discuss the source and amount of revenues earned in the period, and revise the disclosure on page 8 and elsewhere that currently indicate that to date you have not produced any revenue. Stock-Based Compensation, page F-7 18.We note from page F-4 that you have recorded stock compensation expenses during each reported period. Please include a note to the financial statements to provide all required disclosures under ASC 718-10-50. Include clear disclosure of how you determined the fair value of your common stock used in calculating the amount of stock-based compensation expense relating to each grant. This comment also applies to the financial statements for the fiscal years ended December 31, 2022 and 2021, respectively. 19.We note that the offering price of your common stock is $2.00 per share. We also note from page F-11 that during the year-to-date period ended October 31, 2023, you have valued your common stock issued for services between $0.25 and $0.50 per share and that you issued warrants with an exercise price of $0.25 per share. Please explain to us the significant factors contributing to the difference between the offering price and the value of your common stock and warrants issued in 2023. 20.In this regard, tell us whether the sales of your common stock for cash to date during 2023 were arms-length transactions to independent third parties. Otherwise, describe to us your relationships with the purchasers. In addition to the 500,000 shares of common stock issued for cash during the six months ended June 30, 2023, please separately address each of the sales of common stock made on July 1, 2023, July 11, 2023, October 5, 2023, and October 31, 2023, as disclosed in Note 11-Subsequent Events on page F-11, as well as any additional cash sales consummated prior to your next amendment.

FirstName LastNameSteven Luna Comapany NameAlternative Ballistics Corporation November 28, 2023 Page 5 FirstName LastName Steven Luna Alternative Ballistics Corporation November 28, 2023 Page 5 Please contact Andi Carpenter at 202-551-3645 or Martin James at 202-551-3671 if you have questions regarding comments on the financial statements and related matters. Please contact Jenny O'Shanick at 202-551-8005 or Evan Ewing at 202-551-5920 with any other questions. Sincerely, Division of Corporation Finance Office of Manufacturing cc: Lynne Bolduc

Show Raw Text
United States securities and exchange commission logo
November 28, 2023
Steven Luna
Chief Executive Officer
Alternative Ballistics Corporation
5940 S. Rainbow Blvd.
Las Vegas, Nevada 89118
Re:Alternative Ballistics Corporation
Amendment No. 1 to Offering Statement on Form 1-A
Filed November 6, 2023
File No. 024-12349
Dear Steven Luna:
            We have reviewed your amended offering statement and have the following comment(s).
            Please respond to this letter by amending your offering statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response.
            After reviewing any amendment to your offering statement and the information you
provide in response to this letter, we may have additional comments.
Amendment No 1 to Registration Statement on Form 1-A
Cover page
1.We note your disclosure that the offering will “terminate at the earlier of (i) the date at
which the Maximum Offering set forth above has been sold, or (ii) the date at which this
Offering is earlier terminated by us at our sole discretion.” We also note your disclosure
on page 6 that the offering will "terminate at the earlier of (i) the date at which the
Maximum Offering set forth above has been sold, (ii) one year from the qualification of
this Offering, or (iii) the date at which this Offering is earlier terminated by us at our sole
discretion." Please revise.
2.We note your disclosures that your directors, executive officers and significant
stockholders may be able to influence your company and that your Chief Executive
Officer has 68.2% voting control “through his ownership of 2,000,000 shares of Series A
Preferred Stock, which has 100 to 1 voting rights.” If true, please revise the cover page to
prominently disclose that the company will be a controlled company post-offering,
identify the controlling stockholder(s) and such stockholders’ total voting power, and

 FirstName LastNameSteven Luna
 Comapany NameAlternative Ballistics Corporation
 November 28, 2023 Page 2
 FirstName LastName
Steven Luna
Alternative Ballistics Corporation
November 28, 2023
Page 2
include appropriate risk factor disclosure.
3.We note your disclosure on page 52 that the "Selling Stockholders may only make offers
and sales of their shares of up to 30% of the gross proceeds from this Offering.” Please
revise your cover page to include this disclosure.
4.We note your disclosure that you are an emerging growth company and that more
information can be found in the section entitled “Offering Circular
Summary—Implications of Being an Emerging Growth Company,” however, this section
does not appear. Please advise or revise. Further, please revise to include a risk factor
disclosing that you are an emerging growth company and discuss any related material
risks.
Summary Financial Data, page 7
5.Please revise the table to remove the parenthetical disclosure indicating "audited" and
"unaudited" above the columns since your auditors have not issued an audit report
covering this table and therefore all amounts are unaudited. Instead, if true, you
could revise the introductory paragraph to indicate that the amounts presented as of and
for the six months ended June 30, 2023 and 2022 were derived from your unaudited
interim financial statements, and the amounts presented as of and for the years ended
December 31, 2022 and 2021 were derived from your audited financial statements,
presented elsewhere in the filing.
Use of Proceeds, page 23
6.We note your anticipated use of proceeds if you raise the Maximum Offering amount.
Please revise to describe any anticipated material changes in the use of proceeds if all of
the securities being qualified on the offering statement are not sold.
Capitalization, page 24
7.We note that you only present a "pro forma as adjusted" column that gives effect to the
maximum offering. Please revise the introductory paragraphs to clearly disclose that this
is a best-efforts offering with no minimum offering required.  Further, refer to the
guidance in Rule 11-02(a)(10) of Regulation S-X and revise to provide additional columns
that assume varying amounts of possible sales (e.g., 25%, 50%, 75%).
8.Please remove the parenthetical disclosure above the columns indicating that the "Pro
Forma and Pro Forma As Adjusted are unaudited" and that the Actual amounts for June
30, 2023 have been "reviewed," since your auditors have not issued an audit or review
report covering this table. We note that all amounts presented are unaudited. If true, you
could revise the introductory paragraph to say that the amounts presented in the Actual
column were derived from your unaudited interim financial statements for the six months
ended June 30, 2023 included elsewhere in the filing.

 FirstName LastNameSteven Luna
 Comapany NameAlternative Ballistics Corporation
 November 28, 2023 Page 3
 FirstName LastName
Steven Luna
Alternative Ballistics Corporation
November 28, 2023
Page 3
9.Please revise the table to correctly calculate total capitalization for all columns presented
as the sum of total liabilities and total shareholders’ equity (deficit). For example, total
capitalization as of June 30, 2023, in the Actual column, appears to be $105,990.
Dilution, page 25
10.As this is a best-efforts offering with no minimum offering required, please revise the
dilution information to include a sensitivity analysis reflecting varying amounts of
possible sales (e.g., 25%, 50%, 75%), to supplement the current Maximum Offering
presentation.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Liquidity and Capital Resources, page 28
11.Please revise to describe all material cash requirements, including short-term and long-
term requirements, and the anticipated source of funds needed to satisfy such cash
requirements. Further, please revise this section to discuss all current material debt of the
company.
Business
Our Historical Growth and Growth Strategy, page 36
12.We note your disclosure on page 8 that you have not produced any revenue as well as
your disclosure that you recently secured your “first purchase order from a department in
Florida, and may have generated anticipated purchase orders from several departments in
South America.” If material, please revise to clearly describe the material terms of the
purchase order, including if any purchase orders are non-binding.
Management
Directors and Executive Officers, page 43
13.Please revise to briefly discuss the specific experience, qualifications, attributes or skills
that led to the conclusion that each of your directors should serve as your director.
Certain Relationships and Related-Party Transactions, page 50
14.We note the related party transactions disclosed on pages F-9 and F-10. Additionally, we
note your disclosure that Vanessa Luna’s consulting firm provided consultation services to
you. Please revise to include the disclosures required by Item 13 of Form 1-A, including
the dollar amount of each transaction.
Security Ownership of Certain Beneficial Owners, Management, and Selling Stockholders, page
51
15.We note your disclosure that your Chief Executive Officer owns 2 million shares of your
Series A Preferred Stock. Please revise this table to disclose the beneficial ownership of

 FirstName LastNameSteven Luna
 Comapany NameAlternative Ballistics Corporation
 November 28, 2023 Page 4
 FirstName LastName
Steven Luna
Alternative Ballistics Corporation
November 28, 2023
Page 4
your Series A Preferred Stock.
Plan of Distribution, page 62
16.We note your disclosure regarding rolling closings and that "[i]f the Initial Closing never
occurs, the proceeds from the Offering will be promptly returned to investors." Please
provide expanded disclosure regarding your rolling closings, including whether you may
terminate the offering without ever having a closing. Please also provide us your analysis
as to whether your offering should be considered to be a delayed offering and not a
continuous offering within the meaning of Rule 251(d)(3)(i)(F) of Regulation A.
Notes to the Financial Statements (Unaudited)
2. Significant Accounting Policies, page F-5
17.We note you recognized revenue in the six-month period that ended June 30, 2023. Please
revise to disclose the source of that revenue and your revenue recognition policy.  Refer to
ASC 606-10-50. In addition, revise your MD&A to discuss the source and amount of
revenues earned in the period, and revise the disclosure on page 8 and elsewhere that
currently indicate that to date you have not produced any revenue.
Stock-Based Compensation, page F-7
18.We note from page F-4 that you have recorded stock compensation expenses during each
reported period. Please include a note to the financial statements to provide all required
disclosures under ASC 718-10-50. Include clear disclosure of how you determined the fair
value of your common stock used in calculating the amount of stock-based compensation
expense relating to each grant. This comment also applies to the financial statements for
the fiscal years ended December 31, 2022 and 2021, respectively.
19.We note that the offering price of your common stock is $2.00 per share. We also note
from page F-11 that during the year-to-date period ended October 31, 2023, you have
valued your common stock issued for services between $0.25 and $0.50 per share and that
you issued warrants with an exercise price of $0.25 per share. Please explain to us the
significant factors contributing to the difference between the offering price and the value
of your common stock and warrants issued in 2023.
20.In this regard, tell us whether the sales of your common stock for cash to date during
2023 were arms-length transactions to independent third parties. Otherwise, describe to us
your relationships with the purchasers. In addition to the 500,000 shares of common stock
issued for cash during the six months ended June 30, 2023, please separately address each
of the sales of common stock made on July 1, 2023, July 11, 2023, October 5, 2023, and
October 31, 2023, as disclosed in Note 11-Subsequent Events on page F-11, as well as any
additional cash sales consummated prior to your next amendment.

 FirstName LastNameSteven Luna
 Comapany NameAlternative Ballistics Corporation
 November 28, 2023 Page 5
 FirstName LastName
Steven Luna
Alternative Ballistics Corporation
November 28, 2023
Page 5
            Please contact Andi Carpenter at 202-551-3645 or Martin James at 202-551-3671 if you
have questions regarding comments on the financial statements and related matters. Please
contact Jenny O'Shanick at 202-551-8005 or Evan Ewing at 202-551-5920 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing
cc:       Lynne Bolduc